301122 Stock Overview
Engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Caina Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥23.16 |
| 52 Week High | CN¥44.20 |
| 52 Week Low | CN¥14.61 |
| Beta | 0.68 |
| 11 Month Change | 17.98% |
| 3 Month Change | 34.73% |
| 1 Year Change | -43.84% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -41.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301122 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 7.7% | -2.7% | -2.1% |
| 1Y | -43.8% | -11.3% | 2.8% |
Return vs Industry: 301122 underperformed the CN Medical Equipment industry which returned -7.3% over the past year.
Return vs Market: 301122 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 301122 volatility | |
|---|---|
| 301122 Average Weekly Movement | 10.0% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 301122 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301122's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 689 | Jun Lu | www.caina.ltd |
Caina Technology Co., Ltd. engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina Technology Co., Ltd.
Caina Technology Co., Ltd. Fundamentals Summary
| 301122 fundamental statistics | |
|---|---|
| Market cap | CN¥2.83b |
| Earnings (TTM) | CN¥77.32m |
| Revenue (TTM) | CN¥409.00m |
36.6x
P/E Ratio6.9x
P/S RatioIs 301122 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301122 income statement (TTM) | |
|---|---|
| Revenue | CN¥409.00m |
| Cost of Revenue | CN¥249.54m |
| Gross Profit | CN¥159.46m |
| Other Expenses | CN¥82.13m |
| Earnings | CN¥77.32m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.63 |
| Gross Margin | 38.99% |
| Net Profit Margin | 18.91% |
| Debt/Equity Ratio | 0% |
How did 301122 perform over the long term?
See historical performance and comparison